摘要
肝癌是常见的恶性肿瘤之一,其病死率高,预后差。微小肝癌和小肝癌的早期发现和早期治疗,能够有效提高肝癌患者的生存率。目前国内外针对微小肝癌和小肝癌的病因、临床表现、检查和治疗进行了大量研究,达成了许多共识,但在选择最佳的检查方式和治疗手段等方面尚存分歧。针对这些共识和分歧,作者查阅相关文献予以综述。
Hepatocellular carcinoma(HCC)is one of the most common malignant tumors with high mortality and poor prognosis.Early detection and early treatment of micro-small hepatocellular carcinoma(MHCC)and small hepatocellular carcinoma(SHCC)can effectively improve the survival rate of patients.At present,a large number of studies have been conducted on the etiology,clinical manifestations,examination and treatment of MHCC and SHCC at home and abroad.In view of these consensuses and differences,the author reviews the relevant literature.
作者
齐峰
戴朝六
Qi Feng;Dai Chaoliu(Department of Hepatobiliary and Splenic Surgery,Shengjing Hospital of China Medical University,Liaoning Shenyang 110004,China)
出处
《现代肿瘤医学》
CAS
2020年第6期1048-1052,共5页
Journal of Modern Oncology
基金
2017年辽宁省重点研发计划(编号:2017225032)